Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes

Experimental Parasitology

Volumn 134, Issue 2, 2013, Pages 183-189

  Peres, Raphael Sanches ^a   Chiuso Minicucci, Fernanda ^a   da Rosa, Larissa Camargo ^a   Domingues, Alexandre ^a   Zorzella Pezavento, Sofia Fernanda Gonçalves ^a   França, Thais Graziela Donegá ^a   Ishikawa, Larissa Lumi Watanabe ^a   do Amarante, Alessandro Francisco Talamini ^a   Sartori, Alexandrina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Experimental diabetes; Hygiene hypothesis; S. venezuelensis; Streptozotocin

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INSULIN; INTERLEUKIN 10; INTERLEUKIN 5; PARASITE ANTIGEN; STRONGYLOIDES VENEZUELENSIS ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STRONGYLOIDES VENEZUELENSIS; STRONGYLOIDIASIS; TREATMENT RESPONSE; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES, HELMINTH; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FECES; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; PARASITE EGG COUNT; RATS; RATS, WISTAR; SPLEEN; STREPTOZOCIN; STRONGYLOIDES; STRONGYLOIDIASIS; TH2 CELLS;

ANIMALIA; MUS; STRONGYLOIDES VENEZUELENSIS; VERMES;

EID: 84876318616     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.03.007     Document Type: Article

References (44)

1. Baek B.K., Islam M.K., Kim B.S., et al. Characterization of the protective response against a homologous challenge infection with Strongyloides venezuelensis in rats. Vet. Parasitol. 2003, 113:217-227.
2. Brás A., Aguas A.P. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 1996, 89:20-25.
3. Chentoufi A.A., Binder N.R., Berka N., Abunadi T., Polychronakos C. Advances in type I diabetes associated tolerance mechanisms. Scand. J. Immunol. 2008, 68:1-11.
4. Chiuso-Minicucci F., Marra N.M., Zorzella-Pezavento S.F.G., et al. Recovery from Strongyloides venezuelensis infection in Lewis rats is associated with a strong Th2 response. Parasite Immunol. 2010, 32:74-78.
5. Cooke A., Tonks P., Jones F.M., et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999, 21:169-176.
6. Cooke A., Zaccone P., Raine T., Phillips J.M., Dunne D.W. Infection and autoimmunity: are we winning the war, only to lose the peace?. Trends Parasitol. 2004, 20:316-321.
7. Cortes L.M., Avichezer D., Silver P.B., et al. Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells. J. Leukoc. Biol. 2008, 84:577-585.
8. El-Wakil H.S., Aboushousha T.S., El Haddad O., Gamil N.B., Mansour T., El-Said H. Effect of Schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes. J. Egypt. Soc. Parasitol. 2002, 32:987-1002.
9. Espinoza-Jiménez A., Rivera-Montoya I., Cárdenas-Arreola R., Morán L., Terrazas L.I. Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J. Biomed. Biotechnol. 2010, 2010:850541.
10. Fernandes A., Pereira A.T.M., Eschenazi P.D., et al. Evaluation of the immune response against Strongyloides venezuelensis in antigen-immunized or previously infected mice. Parasite Immunol. 2008, 30:139-149.
11. Flohr C., Quinnell R.J., Britton J. Do helminth parasites protect against atopy and allergic disease?. Clin. Exp. Allergy. 2009, 39:20-32.
12. Gao X., Ding G., Wang Z., et al. Adjuvant treatment suppresses IL-17 production by T cell-independent myeloid sources in nonobese diabetic mice. Mol. Immunol. 2010, 47:2397-2404.
13. Gordon H.M., Whitlock H.V. A new technique for counting nematode eggs in sheep feces. J. Counc. Sci. Ind. Res. 1939, 12:50-52.
14. Grove D.I. Human strongyloidiasis. Adv. Parasitol. 1996, 38:251-309.
15. Hübner M.P., Stocker J.T., Mitre E. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 2009, 127:512-522.
16. Júnior A.F., Gonçalves-Pires M.R., Silva D.A., Gonçalves A.L., Costa-Cruz J.M. Parasitological and serological diagnosis of Strongyloides stercoralis in domesticated dogs from southeastern Brazil. Vet. Parasitol. 2006, 136:137-145.
17. Kauri L.M., Wang G.S., Patrick C., et al. Increased islet neogenesis without increased islet mass precedes autoimmune attack in diabetes-prone rats. Lab. Invest. 2007, 87:1240-1251.
18. Kimura E., Shintoku Y., Kadosaka T., Fujiwara M., Kondo S., Itoh M. A second peak of egg excretion in Strongyloides ratti-infected rats: its origin and biological meaning. Parasitology 1999, 119:221-226.
19. Kolb H. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab. Rev. 1987, 3:751-778.
20. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976, 193:415-417.
21. Machado E.R., Ueta M.T., Lourenço E.V., et al. Comparison of immune response in mice infected with different strains of Strongyloides venezuelensis. Parasite Immunol. 2007, 29:549-557.
22. Machado E.R., Ueta M.T., Lourenço E.V., et al. Leukotrienes play a role in the control of parasite burden in murine strongyloidiasis. J. Immunol. 2005, 175:3892-3899.
23. Machado-Silva J.R., Neves R.H., Rodrigues-Silva R. Do schistosomes grow old? A confocal laser scanning microscopy study. J. Helminthol. 2010, 84:305-311.
24. Manirarora J.N., Kosiewicz M.M., Parnell S.A., Alard P. APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development. PLoS One 2008, 3:e3739.
25. Marra N.M., Chiuso-Minicucci F., Machado G.C., et al. Faecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats. Mem. Inst. Oswaldo Cruz 2010, 105:57-61.
26. Maruyama H., Nishimaki A., Takuma Y., et al. Successive changes in tissue migration capacity of developing larvae of an intestinal nematode Strongyloides venezuelensis. Parasitology 2006, 132:411-418.
27. McInerney M.F., Pek S.B., Thomas D.W. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 1991, 40:715-725.
28. Morales-Montor J., Baig S., Mitchell R., Deway K., Hallal-Calleros C., Damian R.T. Immunoendocrine interactions during chronic cysticercosis determine male mouse feminization: role of IL-6. J. Immunol. 2001, 167:4527-4533.
29. Perone M.J., Bertera S., Shufesky W.J., et al. Suppression of autoimmune diabetes by soluble galectin-1. J. Immunol. 2009, 182:2641-2653.
30. Qin H.Y., Chaturvedi P., Singh B. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-γ/TNF-α. Int. Immunol. 2004, 16:1723-1732.
31. Qin H.Y., Elliott J.F., Lakey J.R., Rajotte R.V., Singh B. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy. J. Autoimmun. 1998, 11:591-601.
32. Qin H.Y., Singh B. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 1997, 10:271-278.
33. Rerup C.C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 1970, 22:485-518.
34. Romani L. Parasites and autoimmunity: the case of fungi. Autoimmun. Rev. 2008, 8:129-133.
35. Ryu S., Kodama S., Ryu K., Schoenfeld D.A., Faustman D.L. Reversal of established autoimmune diabetes by restoration of endogenous β cell function. J. Clin. Invest. 2001, 108:63-72.
36. Schiefke I., Schmäschke R., Ott R., Schiefke F., Mössner J., Schubert S. Indigenous helminthiasis Internist. Internist (Berl) 2006, 47:793-794.
37. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J. Autoimmun. 2010, 34:168-177.
38. Tindall N.R., Wilson P.A. Criteria for a proof of migration routes of immature parasites inside hosts exemplified by studies of Strongyloides ratti in the rat. Parasitology 1988, 96:551-563.
39. van Duivenvoorde L.M., Han W.G., Bakker A.M., et al. Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J. Immunol. 2007, 179:1506-1515.
40. Vercelli D. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr. Opin. Immunol. 2006, 18:733-737.
41. Whary M.T., Fox J.G. Th1-mediated pathology in mouse models of human disease is ameliorated by concurrent Th2 responses to parasite antigens. Curr. Top. Med. Chem. 2004, 4:531-538.
42. Wilson M.S., Maizels R.M. Regulation of allergy and autoimmunity in helminth infection. Clin. Rev. Allergy Immunol. 2004, 26:35-50.
43. Zaccone P., Burton O., Miller N., Jones F.M., Dunne D.W., Cooke A. Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol. 2009, 39:1098-1107.
44. Zaccone P., Burton O.T., Cooke A. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol. 2008, 24:35-42.